Publications by authors named "Yilai Gao"
Article Synopsis
- The study aims to find common therapeutic targets for two types of retroperitoneal liposarcoma: well-differentiated and dedifferentiated.
- Researchers analyzed clinical and gene expression data to determine survival differences and identify important genes and proteins involved in the disease.
- The results show significant survival differences between the two liposarcoma types, highlight key hub genes, and suggest four potential therapeutic drugs, paving the way for new treatment strategies.
Article Synopsis
- Fibrosarcoma is a serious type of cancer with high invasiveness and recurrence, typically treated with anthracycline drugs like doxorubicin (DOX), which may not be very effective alone.
- New strategies are being explored that combine chemotherapy with immunotherapy, specifically using a dendritic cell (DC) nanovaccine to improve treatment outcomes.
- The innovative nanovaccine, cGAMP@PLGA@CRTM, uses a unique approach that enhances immune response while minimizing side effects from low-dose DOX, presenting a promising new treatment for fibrosarcoma patients.*
